Benefits/Effectiveness of Pulmonary Surfactant Therapy in Ne

发布时间：2020-12-11 19:56

　　Neonatal Respiratory distress syndrome （NRDS）, is an acute lung disease of the newborncaused by surfactant deficiency. It is one of the most common causes of respiratory failures inpremature babies, especially in neonates younger than32weeks’ gestational age andweighing less than1200g. Ventilation was used to improve oxygenation and diseasedmortality of neonates with NRDS, but it may cause severe lung injury includingpneumothorax, ventilator-associated pneumonia and increase the incidence of chr... 

【文章来源】：华中科技大学湖北省 211工程院校 985工程院校 教育部直属院校

【文章页数】：47 页

【学位级别】：硕士

【文章目录】：
Table of Contents
Abbreviations
Abstract
Neonatal respiratory distress syndrome
History of pulmonary surfactant therapy
Synthesis of endogenous pulmonary surfactant
Composition of pulmonary surfactant
Function of Pulmonary Surfactant
Pulmonary Surfactant Preparations
Comparison of High and low dose natural surfactants
Earlier surfactant treatment policy
Benefits of exogenous pulmonary surfactant therapy in NRDS
Timing of surfactant administration
Pulmonary surfactant Usage
Surfactant therapy in other neonatal lung disease
Methods of Administration of Exogenous Pulmonary Surfactant
A Case Report
Summary
Conclusion
References
Acknowledgement


【参考文献】：
期刊论文
[1]表面活性物质替代治疗新生儿呼吸窘迫综合征的疗效评估(英文)[J]. Sedigheh GHAEMI,Maryam MOHAMADYMASODI,Roya KELISHADI.  中国当代儿科杂志. 2009(03)



本文编号：2911131